CRA
ABBV icon

Clear Rock Advisors’s AbbVie ABBV Stock Holding History

Clear Rock Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$3.49M Buy
20,348
+427
+2% +$70.7K 1.49% 18
2024
Q1 		$3.63M Buy
19,921
+141
+0.7% +$24.3K 1.58% 16
2023
Q4 		$3.44M Buy
+19,780
New +$2.88M 1.56% 17

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Clear Rock Advisors's ABBV Position: Q2 2024 in Review

Clear Rock Advisors increased its AbbVie (ABBV) stake by 2.1% in Q2 2024, buying an estimated $70.7K and bringing the position to 20,348 shares worth $3.49M. The position accounts for 1.49% of the portfolio, ranked #18.

Clear Rock Advisors first reported a position in ABBV in Q4 2023 and has held it in 3 quarters since. The position peaked at $3.63M in Q1 2024. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Clear Rock Advisors held 20,348 shares of AbbVie worth $3.49M as of Q2 2024.
  • Clear Rock Advisors bought 427 AbbVie shares in Q2 2024, an estimated $70.7K.
  • AbbVie made up 1.49% of Clear Rock Advisors's portfolio in Q2 2024, its #18 holding.
  • Clear Rock Advisors first reported a position in AbbVie in Q4 2023 and has held it in 3 quarters since.
  • Clear Rock Advisors's AbbVie position peaked at $3.63M in Q1 2024.
  • 3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Clear Rock Advisors's 13F filing for Q2 2024, filed 3 Sep 2024.